Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension

NCT: NCT03945305 · RECRUITING

NCT IDNCT03945305
StatusRECRUITING
Start Date2023-11-25
Completion2026-07-31
SponsorYi Yang (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to explore the efficacy and safety of remote ischemic conditioning for essential hypertension in the community population.

Frequently Asked Questions

What is Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension?

Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension is a clinical trial registered under NCT03945305. Current status: RECRUITING.

What is the status of NCT03945305?

The current status of NCT03945305 (Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension) is: RECRUITING.

When did Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension start?

Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension started on 2023-11-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑